Dr. Kerslake is the CEO of Topera Medical (acquired by Abbott).

Prior to Topera, Dr. Kerslake was the Corporate Vice President, Portfolio Management at Boston Scientific and the Chief Operating Officer at MDdatacor, a cardiology/healthcare IT company.

Previously, he spent five years at The Monitor Group, a global strategy consulting firm based in Cambridge, MA. Before joining Monitor, Dr. Kerslake worked as Senior Scientist and Head of Formulation for Allergan (NYSE:AGN).

Dr. Kerslake holds an M.B.A. from the University of California, Irvine and a Ph.D. in Pharmaceutical Sciences–Drug Delivery from Cardiff University.